Your article was successfully shared with the contacts you provided.
Just as other products have seen sales and profits go through the roof as people stocked up on goods in response to lockdowns, pharmaceutical company Eli Lilly has not only beat quarterly estimates but also boosted its profit forecast for 2020 as customers have stocked up on such drugs as its diabetes drug Trulicity and psoriasis drug Taltz.
According to a Reuters report, the company did warn that the phenomenon would likely reverse over the course of the year and it could still be hit with a negative impact to drug prices given the toll coronavirus is taking on the economy.
Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.
Your access to unlimited BenefitsPRO.com content isn’t changing. Once you are an ALM digital member, you’ll receive:
Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Competing successfully in today’s labor market means moving away from reactive recruitment practices that are overly reliant on compensation. Instead, take a more strategic approach with innovative add-on health benefits that complement core benefits and can be tailored to the needs and wants of a diverse workforce. Download this guide to learn how.